Recent studies have shown the contribution of TCTP in cell growth and proliferation of prostate cancer, suggesting TCTP as a novel possible therapeutic target in the treatment of castration-resistant PC [9, 19]. This evidence concerns the gene TPT1 and pachyonychia congenita.